Prospectus Supplement No. 1 | Filed Pursuant to Rule 424(b) and (c) File No. 333-115813 |
24,302,459 SHARES
AEROGEN, INC.
COMMON STOCK
This prospectus supplement supplements the prospectus, dated August 17, 2004, of Aerogen, Inc. relating to the offering and sale by selling stockholders of Aerogen (or by donees, transferees and other successors in interest that receive such shares as a gift, pledge, partnership distribution or other non-sale transfer) of up to 24,302,459 shares of our common stock, which includes 11,420,940 shares of common stock issuable to the selling stockholders upon conversion of Series A-1 Preferred Stock, 11,331,519 shares of common stock issuable to the selling stockholders upon the exercise of warrants to purchase common stock, 50,000 shares of common stock issued to CA-Shoreline Technology Park Limited Partnership, and 1,500,000 shares of common stock as a good faith estimate of dividends payable to the holders of Series A-1 Preferred Stock. We will not receive any proceeds from the sale of the shares of common stock by the selling stockholders.
INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK.
SEE "RISK FACTORS" BEGINNING ON PAGE 1 OF THE PROSPECTUS.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus supplement is December 6, 2004.
The text, table and related notes appearing in the prospectus, dated August 17, 2004, under the heading "Selling Stockholders" is superseded by the following text, table and related notes:
On January 23, 2004, we issued a secured convertible debenture, in the principal amount of $500,000, and warrant to the Carpenter 1983 Family Trust UA (the "Carpenter Trust"). The warrant (the "Carpenter Warrant") is exercisable on or after July 26, 2004 for up to 82,129 shares of our common stock at an exercise price of $3.044 per share, and expires on January 23, 2008.
On March 11, 2004, we entered into a Purchase Agreement (the "Purchase Agreement") with Xmark Fund, L.P., Xmark Fund, Ltd., and the other investors set forth on Schedule I, Schedule II and Schedule III to the Purchase Agreement (collectively, the "Investors"). Pursuant to the Purchase Agreement, we issued 1,142,094 shares of Series A-1 Convertible Preferred Stock (the "Preferred Stock") to the Investors (the "Financing"). The Preferred Stock is convertible for up to 11,420,940 shares of common stock at a conversion price of $3.00 per share. In addition to the Preferred Stock, the Company issued the Investors warrants to purchase up to 11,249,390 shares of common stock at an exercise price of $3.25 per share (the "Warrants"). Each holder of Preferred Stock is entitled to cumulative dividends at a rate of $1.80 per share of Preferred Stock per annum, payable quarterly out of legally available funds or in common stock.
As part of the Financing, SF Capital Partners, Ltd. ("SF Capital") and the Carpenter Trust agreed to exchange the outstanding debentures previously issued to them for an aggregate of 52,232 shares of Preferred Stock. SF Capital also received a warrant to purchase up to 350,770 shares of our common stock at an exercise price of $3.25 per share in connection with its debt exchange.
The terms of the Preferred Stock and Warrants preclude each Investor from converting Preferred Stock or exercising Warrants if the conversion or exercise would result in the Investor and/or its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following the conversion or exercise. Each Investor can waive this provision with respect to the Preferred Stock or Warrants it holds by providing 61 days' advance written notice to the Company. In addition, no warrant issued to SF Capital can be exercised if it would result in SF Capital and/or its affiliates beneficially owning more than 9.999% of our outstanding common stock. This provision cannot be waived.
We intend to issue a total of 361,638 shares of common stock as dividends on the Preferred Stock payable on April 1, 2004, July 1, 2004 and October 1, 2004. If we continue to elect to pay the quarterly dividend due on the Preferred Stock with shares of common stock, the actual number of common shares issuable in satisfaction of such quarterly dividends will vary with the fair market value of the Company's common stock at the end of each calendar quarter. As it is impossible to predict the fair market value of the Company's common stock in the future, it is impossible to accurately predict how many shares of common stock will be issued to satisfy any one quarterly dividend obligation in the future. Furthermore, it is impossible to predict when or if some or all of the Preferred Stock will convert into common stock, which would terminate the dividend obligation as to such converted shares. Based on our current cash resources, we expect to continue to pay the Preferred Stock dividend in common stock, and our good faith estimate of the number of shares that we will issue to satisfy the dividend over a two-to-three year period is 1,500,000 shares.
An additional 50,000 shares of common stock are also being offered hereunder, consisting of shares of common stock issued to CA-Shoreline Technology Park Limited Partnership ("CA-Shoreline") pursuant to that certain Second Amendment to the Lease Agreement by and between the Company and CA-Shoreline (the "Second Amendment"), dated as of March 9, 2004. The Company agreed to register such additional shares pursuant to registration rights we had granted to CA-Shoreline in connection with the Second Amendment.
The shares being offered hereunder include: (i) the 11,420,940 shares of common stock issuable upon conversion of the Preferred Stock, (ii) the 11,249,390 shares of common stock issuable upon
exercise of the Warrants, (iii) the 1,500,000 shares of common stock estimated to be payable as dividends on the Preferred Stock, (iv) the 82,129 shares of common stock issuable upon exercise of the Carpenter Warrant and (v) the 50,000 shares of common stock issued to CA-Shoreline.
We are registering the above-referenced shares to permit each of the selling stockholders and their pledgees, donees, transferees or other successors-in-interest that receive their shares from each selling stockholder as a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the shares.
The following table sets forth the name of each selling stockholder, the number of shares owned by each of the respective selling stockholders as of September 30, 2004, the number of shares that may be offered under this prospectus and the number of shares of our common stock owned by the selling stockholders after this offering is completed. Except as otherwise disclosed below, none of the selling stockholders has, or within the past three years has had, any position, office or other material relationship with us. The number of shares in the column "Number of Shares Being Offered" represents all of the shares that a selling stockholder may offer under this prospectus, and assumes the exercise of all the warrants for common stock. This number also includes an estimate of the shares of common stock to be issued as quarterly dividends on the Preferred Stock held by the selling stockholders in the amounts included in the footnotes below. These estimates are based on a pro rata allocation among the holders of Preferred Stock of the shares reserved for the quarterly dividend and assume that none of the selling stockholders transfer any of their shares of Preferred Stock or convert any of their shares of Preferred Stock to common stock.
The selling stockholders may sell some, all or none of their shares. We do not know how long the selling stockholders will hold the shares before selling them, and we currently have no agreements, arrangements or understandings with the selling stockholders regarding the sale of any of the shares. The shares offered by this prospectus may be offered from time to time by the selling stockholders.
Our Chief Executive Officer and Chairman of our Board of Directors, Jane E. Shaw, and her husband, Peter Carpenter, are co-trustees of the Carpenter Trust.
Beneficial ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Securities Exchange Act of 1934. Unless otherwise noted, none of the share amounts set forth below represents more than 1% of our outstanding stock as of September 30, 2004, calculated as required by rules promulgated by the SEC. The percentages of shares beneficially owned prior to the offering are based on 4,884,829 shares of our common stock outstanding as of September 30, 2004 (including 100,056 of the 127,906 shares of common stock issuable as quarterly dividend payments on the Preferred Stock for the quarters ended March 31 and June 30, 2004), plus the shares of common stock beneficially owned by the respective selling stockholder, as set forth in the following table and more fully described in footnote 2, below. The percentages of shares beneficially owned after the offering are based on 4,884,829 shares of common stock outstanding as of September 30, 2004, plus 24,152,403 shares of common stock that are being registered in this offering and that are not currently outstanding.
|
Shares of Common Stock Beneficially Owned Prior to Offering(1)(2) |
|
|
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
Shares Beneficially Owned After Offering(3) |
||||||||
Name |
Number of Shares Being Offered |
|||||||||
Number |
Percent |
Number |
Percent |
|||||||
Xmark Fund, Ltd.(4) | 256,555 | 4.99 | % | 1,974,641 | 0 | * | ||||
Xmark Fund, LP(4) | 256,555 | 4.99 | % | 1,577,843 | 0 | * | ||||
TNC Partners II, LLC(5) | 33,851 | * | 35,512 | 0 | * | |||||
Winchester Global Trust Company Limited as Trustee for Caduceus Capital Trust(6) | 256,555 | 4.99 | % | 1,065,750 | 0 | * | ||||
Caduceus Capital II, LP(6) | 256,555 | 4.99 | % | 458,273 | 0 | * | ||||
UBS Eucalyptus Fund, LLC(6) | 256,555 | 4.99 | % | 1,065,750 | 0 | * | ||||
PW Eucalyptus Fund, Ltd.(6) | 256,555 | 4.99 | % | 127,890 | 0 | * | ||||
Finsbury Worldwide Pharmaceutical Trust(6) | 256,555 | 4.99 | % | 1,385,475 | 0 | * | ||||
HFC SHC Aggressive(6) | 256,555 | 4.99 | % | 159,863 | 0 | * | ||||
HealthCap IV, LP(7) | 256,555 | 4.99 | % | 1,948,830 | 0 | * | ||||
HealthCap IV Bis, LP(7) | 256,555 | 4.99 | % | 1,408,178 | 0 | * | ||||
HealthCap IV KB(7) | 256,555 | 4.99 | % | 142,191 | 0 | * | ||||
OFCO Club IV(7) | 256,555 | 4.99 | % | 53,289 | 0 | * | ||||
Perceptive Life Sciences Master Fund, Ltd.(8) | 256,555 | 4.99 | % | 2,841,991 | 0 | * | ||||
North Sound Legacy Fund, LLC(9) | 256,555 | 4.99 | % | 63,945 | 0 | * | ||||
North Sound Legacy International, Ltd.(9) | 256,555 | 4.99 | % | 1,364,159 | 0 | * | ||||
North Sound Legacy Institutional Fund, LLC(9) | 256,555 | 4.99 | % | 703,395 | 0 | * | ||||
Pequot Scout Fund, LP(10) | 256,555 | 4.99 | % | 831,285 | 0 | * | ||||
Pequot Navigator Offshore Fund, Inc.(10) | 256,555 | 4.99 | % | 385,802 | 0 | * | ||||
Pequot Navigator Onshore Fund, LP(10) | 256,555 | 4.99 | % | 204,624 | 0 | * | ||||
SDS Capital Group SPC, Ltd.(11) | 256,555 | 4.99 | % | 1,065,750 | 0 | * | ||||
Bay Star Capital II, LP(12) | 256,555 | 4.99 | % | 1,065,750 | 11,400 | * | ||||
ProMed Partners, LP(13) | 256,555 | 4.99 | % | 475,112 | 32,133 | * | ||||
ProMed Partners II, LP(13) | 256,555 | 4.99 | % | 87,607 | 32,133 | * | ||||
ProMed Offshore Fund, Ltd.(13) | 256,555 | 4.99 | % | 76,734 | 32,133 | * | ||||
Paul Scharfer(13) | 256,555 | 4.99 | % | 177,619 | 32,133 | * | ||||
David B. Musket(13) | 256,555 | 4.99 | % | 170,521 | 32,133 | * | ||||
Ursus Capital, LP(14) | 396,856 | 8.28 | % | 383,670 | 386,193 | * | ||||
Ursus Offshore, Ltd.(14) | 396,856 | 8.28 | % | 330,383 | 386,193 | * | ||||
Porter Partners, LP(15) | 256,555 | 4.99 | % | 568,386 | 35,310 | * | ||||
EDJ Limited(16) | 139,901 | 2.84 | % | 142,087 | 4,458 | * | ||||
SF Capital Partners, Ltd.(17) | 256,555 | 4.99 | % | 1,456,908 | 255,750 | * | ||||
Anders Hove(18) | 111,592 | 2.28 | % | 106,576 | 10,000 | * | ||||
Paul and Theresa Brown 1994 Trust dated 10/8/94(19) | 67,722 | 1.40 | % | 71,044 | 0 | * | ||||
Carpenter 1983 Family Trust UA(20) | 256,555 | 4.99 | % | 275,626 | 0 | * | ||||
CA-Shoreline Technology Park Limited Partnership(21) | 110,000 | 2.25 | % | 50,000 | 0 | * | ||||
Total | 24,302,459 |
(iii) 740,250 shares issuable upon the exercise of warrants held by Xmark Fund, LP; (iv) 926,410 shares issuable upon the exercise of warrants held by Xmark Fund, Ltd.; (v) 23,560 shares issued or issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by Xmark Fund, LP for the quarters ended March 31, June 30 and September 30, 2004; and (vi) 29,483 shares issued or issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by Xmark Fund, Ltd. for the quarters ended March 31, June 30 and September 30, 2004, for a total of 3,386,363 shares which would, in aggregate, represent 41.44% of the Company's outstanding common stock. However, the terms of such Preferred Stock and Warrants preclude the holders thereof from converting or exercising (as applicable) its Preferred Stock or Warrants (as applicable) if such conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. On November 3, 2004, Xmark Fund, LP and Xmark Fund, Ltd, provided a written waiver of this limitation to the Company. Accordingly, beginning January 3, 2005, this 4.99% limitation on conversion will no longer apply to the shares of Preferred Stock held by these two funds Also includes (i) 73,783 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Xmark Fund, LP; and (ii) 92,338 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Xmark Fund, Ltd. Xmark Asset Management, LLC ("XAM"), serves as investment manager for each of Xmark Fund, LP and Xmark Fund, Ltd., as well as various other private investment funds. Mitchell D. Kaye is the Manager of XAM, and as such, Mr. Kaye possesses the power to vote and direct the disposition of all securities held by Xmark Fund, LP and Xmark Fund, Ltd.
dividends on the Preferred Stock held by PW Eucalyptus Fund, Ltd. for the quarters ended March 31, June 30 and September 30, 2004; (xvii) 20,687 shares issued of issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by Finsbury Worldwide Pharmaceutical Trust for the quarters ended March 31, June 30 and September 30, 2004; and (xviii) 2,388 shares issued or issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by HFC SHC Aggressive for the quarters ended March 31, June 30 and September 30, 2004, for a total of 4,063,654 shares which would, in aggregate, represent 45.93% of the Company's outstanding common stock. However, the terms of such Preferred Stock and Warrants preclude the holders thereof from converting or exercising (as applicable) its Preferred Stock or Warrants (as applicable) if such conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes (i) 49,837 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Winchester Global Trust Company as Trustee for Caduceus Capital Trust; (ii) 21,430 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Caduceus Capital II, LP; (iii) 49,837 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by UBS Eucalyptus Fund, Ltd.; (iv) 5,980 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by PW Eucalyptus Fund, Ltd.; (v) 64,788 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Finsbury Worldwide Pharmaceutical Trust; and (vi) 7,475 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by HFC SHC Aggressive. OrbiMed Advisors LLC and OrbiMed Capital LLC act as investment advisers to certain collective investment funds. Samuel D. Isaly owns a controlling interest in OrbiMed Advisors LLC and OrbiMed Capital LLC. OrbiMed Capital LLC is the investment adviser for Finsbury Worldwide Pharmaceutical Trust and HFC SHC Aggressive. OrbiMed Advisors LLC is the investment adviser for Winchester Global Trust Company. OrbiMed Advisors LLC is also the general partner of Capital II, which is the joint venture partner of UBS Eucalyptus Fund, LLC and of PW Eucalyptus Fund, Ltd. As such, Mr. Isaly has the power to vote and to direct the disposition of all the securities held by Winchester Global Trust Company, UBS Eucalyptus Fund, LLC, PW Eucalyptus Fund, Ltd., Finsbury Worldwide Pharmaceutical Trust and HFC SHC Aggressive.
common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes (i) 65,850 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by HealthCap IV Bis, LP; (ii) 91,131 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by HealthCap IV, LP; (iii) 6,649 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by HealthCap IV KB; and (iv) 2,492 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by OFCO Club IV. HealthCap IV GP S.A. is the general partner of HealthCap IV, L.P. and HealthCap IV Bis, L.P. and possesses, through its board of directors, the power to vote and direct the disposition of all securities held by HealthCap IV, L.P. and HealthCap IV Bis, L.P. The board of directors of Healthcap IV GP S.A., consists of Peder Fredrikson, a Swedish citizen and Francois Kaiser, a Swiss citizen. HealthCap IV GP AB is the general partner of HealthCap IV KB and possesses, through its board of directors, the power to vote and direct the disposition of all securities held by HealthCap IV KB. The board of directors of HealthCap IV GP AB consists of Johan Christenson, Anki Forsberg, Staffan Lindstrand, Magnus Persson, Björn Odlander and Per Samuelsson, each of whom are Swedish citizens. Odlander Fredrikson & Co AB as a member of OFCO Club IV and acting on behalf of the other members of OFCO Club IV has the power to vote and direct the disposition of all securities held by OFCO Club IV. Odlander Fredrikson & Co. AB is in turn controlled by Mr. Fredrikson and Mr. Odlander. Each of HealthCap IV, L.P., HealthCap IV Bis, L.P., HealthCap IV KB and OFCO Club IV are parties to a parallel investment agreement pursuant to which each of them has agreed to invest in parallel. The Odlander, Fredrikson Group acts as investment advisor to each of HealthCap IV, L.P., HealthCap IV Bis, L.P. and HealthCap IV KB.
issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by North Sound Legacy Institutional Fund, LLC for the quarters ended March 31, June 30 and September 30, 2004, for a total of 2,031,826 shares which, in aggregate, would represent 29.81% of the Company's outstanding common stock. However, the terms of such Preferred Stock and Warrants preclude the holders thereof from converting or exercising (as applicable) its Preferred Stock or Warrants (as applicable) if such conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes (i)2,990 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by North Sound Legacy Fund, LLC; (ii) 63,791 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by North Sound Legacy International, Ltd.; and (iii) 32,892 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by North Sounds Legacy Institutional Fund, LLC. North Sound Capital LLC is the investment advisor of North Sound Legacy Fund LLC, North Sound Legacy Institutional Fund LLC, and North Sound Legacy International Ltd. Thomas McAuley is the managing member of North Sound Capital LLC, and is the individual with the power to vote and to direct the disposition of all securities held by North Sound Legacy Fund, LLC, North Sound Legacy International, Ltd. and North Sound Legacy Institutional Fund, LLC.
dividends on the Preferred Stock held by SDS Capital Group SPC Ltd. for the quarters ended March 31, June 30 and September 30, 2004, for a total of 1,015,913 shares which, in aggregate, would represent 17.51% of the Company's outstanding common stock. However, the terms of such Preferred Stock and Warrants preclude the holders thereof from converting or exercising (as applicable) its Preferred Stock or Warrants (as applicable) if such conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes 49,837 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by SDS Capital Group SPC, Ltd. SDS Management, LLC is the investment advisor to SDS Capital Group SPC, Ltd. Steve Derby is the sole managing member of SDS Management, LLC, and as such, is the individual with the power to vote and to direct the disposition of all securities owned by SDS Capital Group SPC, Ltd.
973,544 shares which would, in aggregate, represent 17.00% of the Company's outstanding common stock. However, the terms of such Preferred Stock and Warrants preclude the holders thereof from converting or exercising (as applicable) its Preferred Stock or Warrants (as applicable) if such conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes (i) 22,217 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by ProMed Partners, LP; (ii) 4,097 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Promed Partners II, LP; (iii) 3,588 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Promed Offshore Fund, Ltd.; (iv) 8,306 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Paul Scharfer; and (v) 7,974 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by David B. Musket. ProMed Partners, L.P., ProMed Partners II, L.P. and ProMed Offshore Fund, Ltd. are managed by ProMed Management, Inc. Barry Kurokawa and David B. Musket are the investment managers of ProMed Management, Inc. and as such, Mr. Kurokawa and Mr. Musket possess the power to vote and to direct the disposition of all securities held by ProMed Partners, L.P., ProMed Partners II, L.P., and ProMed Offshore Fund, Ltd.
conversion or exercise (as applicable) would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion or exercise (as applicable), provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes 26,579 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by Porter Partners, LP. Jeffrey H. Porter has the sole power to vote and to direct the disposition of all securities held by Porter Partners, L.P.
Trust UA; and (iii) 4,849 shares issued or issuable in lieu of the cash payment of quarterly dividends on the Preferred Stock held by the Carpenter 1983 Family Trust UA for the quarters ended March 31, June 30 and September 30, 2004, for a total of 258,528 shares which, in the aggregate, would represent 5.13% of the Company's outstanding common stock. However, the terms of the Preferred Stock precludes the conversion into common stock if it would result in such holder and its affiliates beneficially owning in excess of 4.99% of the Company's outstanding common stock following such conversion, provided that such stockholder may waive the provision upon 61 days' written notice to the Company. Also includes 17,098 shares potentially issuable in lieu of the cash payment of future quarterly dividends on the Preferred Stock held by the Carpenter 1983 Family Trust UA. Peter Carpenter and Jane E. Shaw have the power to vote and to direct the disposition of all securities held by the Carpenter 1983 Family Trust UA.